IN8bio, Inc. (INAB)

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $15.46 million. The enterprise value is -$4.13 million.

Market Cap	15.46M
Enterprise Value	-4.13M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

IN8bio has 9.85 million shares outstanding. The number of shares has increased by 315.73% in one year.

Current Share Class	9.85M
Shares Outstanding	9.85M
Shares Change (YoY)	+315.73%
Shares Change (QoQ)	+174.13%
Owned by Insiders (%)	11.53%
Owned by Institutions (%)	24.78%
Float	6.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.50, with a Debt / Equity ratio of 0.10.

Current Ratio	10.50
Quick Ratio	10.17
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.55% and return on invested capital (ROIC) is -56.22%.

Return on Equity (ROE)	-103.55%
Return on Assets (ROA)	-52.75%
Return on Invested Capital (ROIC)	-56.22%
Return on Capital Employed (ROCE)	-80.75%
Weighted Average Cost of Capital (WACC)	4.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.50% in the last 52 weeks. The beta is 0.08, so IN8bio's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-58.50%
50-Day Moving Average	1.56
200-Day Moving Average	1.90
Relative Strength Index (RSI)	51.51
Average Volume (20 Days)	61,276

Short Selling Information

The latest short interest is 245,613, so 2.49% of the outstanding shares have been sold short.

Short Interest	245,613
Short Previous Month	350,153
Short % of Shares Out	2.49%
Short % of Float	3.85%
Short Ratio (days to cover)	3.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.47M
Pretax Income	-18.98M
Net Income	-18.98M
EBITDA	-17.84M
EBIT	-19.47M
Earnings Per Share (EPS)	-$2.21

Balance Sheet

The company has $21.94 million in cash and $2.35 million in debt, with a net cash position of $19.59 million or $1.99 per share.

Cash & Cash Equivalents	21.94M
Total Debt	2.35M
Net Cash	19.59M
Net Cash Per Share	$1.99
Equity (Book Value)	22.78M
Book Value Per Share	2.31
Working Capital	20.50M

Cash Flow

In the last 12 months, operating cash flow was -$14.54 million and capital expenditures -$9,000, giving a free cash flow of -$14.55 million.

Operating Cash Flow	-14.54M
Capital Expenditures	-9,000
Depreciation & Amortization	1.63M
Net Borrowing	-575,000
Free Cash Flow	-14.55M
FCF Per Share	-$1.48

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-315.73%
Shareholder Yield	-315.73%
Earnings Yield	-122.77%
FCF Yield	-94.09%

Analyst Forecast

The average price target for IN8bio is $6.25, which is 301.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.25
Price Target Difference	301.59%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 6, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date	Jun 6, 2025
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	2